Open access · OA
via Europe PMC
Epigenetic age acceleration enhances prediction of overall survival in early-stage non-small cell lung cancer
Gandara I, Du M, Li Y, Su L, Kothari J, Lanuti M, Gainor J, Christiani D.
iScience · 2026
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- Europe PMC
- Canonical
- link ↗
- Fetched
- 2026-10-25 MST
Cite this
APA
I, G., M, D., Y, L., L, S., J, K., M, L., J, G., & D., C. (2026). Epigenetic age acceleration enhances prediction of overall survival in early-stage non-small cell lung cancer. <em>iScience</em>. https://europepmc.org/article/PMC/PMC13691256
Vancouver
I G, M D, Y L, L S, J K, M L, et al. Epigenetic age acceleration enhances prediction of overall survival in early-stage non-small cell lung cancer. iScience. 2026.
BibTeX
@article{gandara2026Epigen,
title = {Epigenetic age acceleration enhances prediction of overall survival in early-stage non-small cell lung cancer},
author = {Gandara I and Du M and Li Y and Su L and Kothari J and Lanuti M and Gainor J and Christiani D.},
journal = {iScience},
year = {2026},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Nature reviews. Cancer 2021
Open access · OA
Interleukins in cancer: from biology to therapy
Zealand University Hospital 2019
Open access · US-GOV
Fit for Surgery. Clinical Randomized Trial of Multimodal Prehabilitation Strategy in Patients With Colorectal Cancer.
Nature 2019
Open access · OA
The enlightenment of age
Twin Research and Human Genetics 2022
Open access · CC-BY
Differences in DNA Methylation-Based Age Prediction Within Twin Pairs Discordant for Cancer
Dana-Farber Cancer Institute 2003
Open access · US-GOV
A Phase II Study of OSI-774 (Tarceva) in Elderly Subjects With Previously Untreated Advanced Non-Small Cell Lung Cancer (NSCLC)
Biomolecules 2026
Open access · OA